b
r
c
tether
isatinferrocen
conjug
synthes
evalu
antiplasmodi
activ
chloroquinesuscept
chloroquineresist
strain
plasmodium
falciparum
conjug
optimum
combin
electronwithdraw
halogen
substitu
posit
isatin
ring
propyl
chain
introduc
linker
prove
potent
noncytotox
among
seri
ic
valu
mm
strain
respect
malaria
one
danger
infecti
diseas
transmit
bite
infect
femal
anophel
mosquito
five
speci
plasmodium
viz
plasmodium
falciparum
plasmodium
oval
plasmodium
malaria
plasmodium
vivax
plasmodium
knowlesi
respons
spread
malaria
p
falciparum
consid
virul
form
accord
world
health
organ
factsheet
billion
peopl
malari
risk
billion
high
risk
one
case
per
peopl
especi
tropic
area
transmiss
countri
million
case
report
global
estim
death
occur
subsaharan
africa
children
age
five
sinc
artemisininbas
combin
therapi
act
recommend
treatment
malaria
howev
develop
resist
recent
time
act
mani
part
southeast
asian
region
great
concern
isatin
versatil
heterocycl
scaffold
vast
possibl
chemic
modif
posit
endogen
molecul
display
wide
rang
biolog
pharmacolog
activ
antitumor
antihiv
antivir
antiangiogen
antifung
antiparkinson
diseas
therapeut
anticonvuls
effect
sar
coronaviru
proteas
inhibitor
along
excel
toler
human
recent
chibal
cowork
disclos
synthesi
antimalari
activ
seri
thiolactoneeisatin
conjug
tetracycl
byproduct
one
potent
conjug
display
ic
valu
mm
chloroquin
resist
cqr
strain
p
falciparum
raval
et
al
describ
synthesi
tetrahydropyrimidineeisatin
hybrid
vitro
activ
strain
p
falciparum
potent
hybrid
exhibit
minimum
inhibitori
concentr
mic
mgml
better
standard
cq
mic
mgml
last
year
wit
close
associ
classic
organometal
chemistri
medicin
biolog
molecular
biotechnolog
prepar
stabl
metal
complex
predict
structur
abil
tune
ligand
affin
along
effici
biolog
target
major
advantag
associ
synthesi
organometal
among
metal
use
ferrocen
fc
play
distinct
role
contemporari
medicin
uniqu
featur
includ
nontox
stabil
physiolog
condit
replac
organ
function
fc
recogn
use
strategi
develop
new
effect
drug
viz
antiandrogen
nilutamid
ferrocenyl
analog
commerci
antiestrogen
tamoxifen
display
higher
cytotox
breast
prostat
cancer
cell
respect
comparison
refer
drug
inde
symbol
exampl
contribut
ferrocen
enhanc
biolog
activ
drug
molecul
ferroquin
fq
deriv
chloroquin
cq
ferrocen
append
side
chain
time
activ
cq
cqr
strain
p
falciparum
privileg
class
five
member
nitrogen
contain
heterocycl
system
attract
attent
synthet
medicin
chemist
due
synthet
applic
biolog
potenti
system
highli
stabl
basic
acid
reduct
oxid
condit
high
aromat
moreov
high
dipol
moment
rigid
stabil
capabl
form
hydrogen
bond
vivo
condit
favor
characterist
bind
biolog
target
previou
report
group
describ
synthesi
vitro
antimalari
potenti
tether
monoand
bisferrocenylchalconeblactam
conjug
well
conjug
chloroquinesuscept
cq
chloroquineresist
cqr
strain
p
falciparum
continu
interest
present
report
describ
synthesi
vitro
antimalari
evalu
tether
isatinferrocen
conjug
depict
fig
synthet
chemistri
substitut
nalkylazidoisatin
prepar
follow
previous
report
protocol
involv
initi
basepromot
alkyl
isatin
dibromoalkan
c
dmf
yield
correspond
substitut
nalkylbromoisatin
subsequ
treatment
sodium
azid
c
result
format
desir
precursor
depict
scheme
precursor
ethnylferrocen
subsequ
util
copper
promot
azidealkyn
cycloaddit
reaction
yield
desir
tether
isatinferrocen
conjug
structur
assign
hybrid
confirm
basi
spectral
data
analyt
evid
compound
exampl
show
molecular
ion
peak
mz
h
nmr
spectrum
exhibit
singlet
correspond
cyclopentadien
ring
ferrocen
along
singlet
due
ferrocen
ring
proton
presenc
characterist
singlet
correspond
triazol
ring
proton
ascertain
assign
structur
corrobor
number
carbon
atom
c
nmr
spectrum
synthes
conjug
evalu
antimalari
potenti
chloroquinesuscept
chloroquineresist
strain
p
falciparum
correspond
inhibitori
concentr
ic
confid
interv
ci
valu
enlist
tabl
synthet
precursor
viz
nalkylbromoisatin
previous
evalu
antimalari
potenti
chloroquineresist
strain
p
falciparum
display
ic
valu
mm
evid
tabl
synthes
conjug
activ
standard
drug
chloroquin
cq
display
consider
activ
strain
conjug
ethyl
chain
introduc
linker
fail
inhibit
growth
even
highest
concentr
test
except
r
h
display
improv
activ
profil
conjug
precursor
viz
nalkylbromoisatin
cq
cqr
strain
p
falciparum
clearli
establish
import
amalgam
ferrocen
nucleu
among
well
establish
isatin
famili
via
triazolelink
reput
physicochem
profil
although
vitro
antimalari
activ
synthes
isatinferrocen
conjug
lower
ferroquin
laboratori
strain
nm
conjug
equipot
ferroceneciprofloxacin
conjug
ferrocenylchalcon
monoand
bisferrocenylchalconesblactam
conjug
cytotox
two
potent
conjug
viz
also
determin
mammalian
hela
cell
list
tabl
evid
conjug
noncytotox
mammalian
cell
therefor
select
inhibit
p
falciparum
conclus
seri
isatinferrocen
conjug
synthes
via
cupromot
azidealkyn
cyloaddit
reaction
evalu
antimalari
activ
strain
p
falciparum
improv
antimalari
efficaci
nalkylbromoisatin
introduct
ferrocen
nucleu
clearli
valid
potenti
introduc
organometal
improv
biolog
efficaci
present
day
drug
discoveri
paradigm
noncytotox
conjug
prove
potent
among
seri
ic
valu
mm
strain
p
falciparum
respect
ethynylferrocen
procur
sigmaealdrich
melt
point
determin
open
capillari
use
veego
precis
digit
melt
point
apparatu
mpd
uncorrect
h
nmr
spectra
record
deuterochloroform
dimethylsulfoxid
jeol
mhz
spectromet
use
tm
intern
standard
chemic
shift
valu
express
part
per
million
downfield
tm
j
valu
hertz
split
pattern
indic
singlet
doublet
triplet
multiplet
dd
doubl
doublet
ddd
doublet
doublet
doublet
br
broad
peak
c
nmr
spectra
record
jeol
mhz
spectromet
deuterochloroform
dimethylsulfoxid
use
tm
intern
standard
element
analys
perform
herau
chneorapid
element
analyz
mass
spectra
record
brucker
high
resolut
mass
spectromet
microtofqii
column
chromatographi
perform
use
silica
gel
mesh
copper
sulfat
mmol
sodium
ascorb
mmol
ad
stir
solut
ethynylferrocen
mmol
nalkyl
azidoisatin
mmol
ethanolwat
mixtur
reaction
mixtur
allow
stir
room
temperatur
h
complet
reaction
evidenc
tlc
water
ml
ad
reaction
mixtur
extract
twice
dichloromethan
ml
combin
organ
layer
dri
anhydr
sodium
sulfat
concentr
reduc
pressur
purifi
via
column
chromatographi
use
etoac
hexan
mixtur
two
strain
viz
cqsuscept
strain
isol
west
africa
obtain
va
usa
isol
indochina
obtain
va
usa
cqresist
strain
maintain
cultur
rpmi
invitrogen
paisley
unit
kingdom
supplement
human
serum
abci
sa
pari
franc
buffer
mm
hepe
mm
nahco
parasit
grown
aposit
human
blood
etabliss
du
sang
marseil
franc
control
atmospher
condit
consist
co
n
c
humid
two
strain
synchron
twice
sorbitol
use
clonal
verifi
everi
day
pcr
genotyp
polymorph
genet
marker
microsatellit
loci
addit
clonal
verifi
year
independ
laboratori
worldwid
antimalari
resist
network
wwarn
chloroquin
diphosph
cq
purchas
sigma
saint
loui
mo
cq
resuspend
water
concentr
rang
nm
synthet
compound
resuspend
dmso
dilut
rpmidmso
obtain
final
concentr
rang
nm
mm
vitro
isotop
microtest
mlwell
antimalari
drug
mlwell
parasit
red
blood
cell
suspens
final
parasitemia
final
hematocrit
distribut
well
plate
parasit
growth
assess
ad
mci
tritiat
hypoxanthin
specif
activ
cimmol
perkineelm
courtaboeuf
franc
well
time
zero
plate
incub
h
control
atmospher
condit
immedi
incub
plate
frozen
thaw
lyse
erythrocyt
content
well
collect
standard
filter
micropl
unifilt
gfb
perkineelm
wash
use
cell
harvest
filterm
cell
harvest
perkineelm
filter
micropl
dri
ml
scintil
cocktail
microscint
perkineelm
place
well
radioact
incorpor
parasit
measur
scintil
counter
top
count
perkineelm
ic
drug
concentr
abl
inhibit
parasit
growth
assess
identifi
drug
concentr
correspond
uptak
tritiat
hypoxanthin
parasit
drugfre
control
well
ic
valu
determin
nonlinear
regress
analysi
logbas
doseerespons
curv
packard
meriden
usa
ic
express
geometr
mean
experi
hela
cell
cultur
mm
tissu
cultur
dish
contain
ml
dulbecco
modifi
eagl
medium
dmem
supplement
penicillin
streptomycin
compound
dissolv
dmso
mm
concentr
cell
cultur
reach
confluenc
ml
compound
ad
dmem
tissu
cultur
dish
final
concentr
mm
cell
incub
h
c
co
incub
h
incub
media
remov
hela
cell
cell
wash
ml
pb
cell
cleav
bottom
plate
via
incub
ml
trypsin
cell
resuspend
ml
pb
transfer
microcentrifug
tube
ml
trypan
blue
solut
ad
resuspend
cell
allow
incub
room
temperatur
approxim
min
viabl
dead
cell
visual
count
hemacytomet
ic
valu
determin
use
graphpad
prism
